Search Results - "Lamorde, M"

Refine Results
  1. 1

    The Effect of Gene Variants on Levonorgestrel Pharmacokinetics When Combined With Antiretroviral Therapy Containing Efavirenz or Nevirapine by Neary, M, Lamorde, M, Olagunju, A, Darin, KM, Merry, C, Byakika‐Kibwika, P, Back, DJ, Siccardi, M, Owen, A, Scarsi, KK

    Published in Clinical pharmacology and therapeutics (01-09-2017)
    “…Reduced levonorgestrel concentrations from the levonorgestrel contraceptive implant was previously seen when given concomitantly with efavirenz. We sought to…”
    Get full text
    Journal Article
  2. 2

    Anti-TB drug concentrations and drug-associated toxicities among TB/HIV-coinfected patients by Sekaggya-Wiltshire, C, von Braun, A, Scherrer, A U, Manabe, Y C, Buzibye, A, Muller, D, Ledergerber, B, Gutteck, U, Corti, N, Kambugu, A, Byakika-Kibwika, P, Lamorde, M, Castelnuovo, B, Fehr, J, Kamya, M R

    Published in Journal of antimicrobial chemotherapy (01-04-2017)
    “…Toxicities due to anti-TB treatment frequently occur among TB/HIV-coinfected patients. To determine the association between anti-TB drug concentrations and the…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Prevalence and type of drug-drug interactions involving ART in patients attending a specialist HIV outpatient clinic in Kampala, Uganda by Seden, K, Merry, C, Hewson, R, Siccardi, M, Lamorde, M, Byakika-Kibwika, P, Laker, E, Parkes-Ratanshi, R, Back, D J, Khoo, S H

    Published in Journal of antimicrobial chemotherapy (01-12-2015)
    “…Scale-up of HIV services in sub-Saharan Africa has rapidly increased, necessitating evaluation of medication safety in these settings. Drug-drug interactions…”
    Get full text
    Journal Article
  5. 5

    Improved Adherence to Antiretroviral Therapy Observed Among HIV-Infected Children Whose Caregivers had Positive Beliefs in Medicine in Sub-Saharan Africa by Abongomera, G., Cook, A., Musiime, V., Chabala, C., Lamorde, M., Abach, J., Thomason, M., Mulenga, V., Kekitiinwa, A., Colebunders, R., Kityo, C., Walker, A. S., Gibb, D. M.

    Published in AIDS and behavior (01-02-2017)
    “…A high level of adherence to antiretroviral treatment is essential for optimal clinical outcomes in HIV infection, but measuring adherence is difficult. We…”
    Get full text
    Journal Article
  6. 6

    Tuberculosis diagnosis in resource-limited settings: Clinical use of GeneXpert in the diagnosis of smear-negative PTB: a case report by Nakiyingi, L, Nankabirwa, H, Lamorde, M

    Published in African health sciences (01-06-2013)
    “…Background: The Xpert MTB/RIF test (GeneXpert) has recently been endorsed for use in resource-limited settings for the diagnosis of tuberculosis and drug…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Challenges in achieving a target international normalized ratio for deep vein thrombosis among HIV-infected patients with tuberculosis: a case series by Sekaggya, C, Nalwanga, D, Von Braun, A, Nakijoba, R, Kambugu, A, Fehr, J, Lamorde, M, Castelnuovo, B

    Published in BMC hematology (04-06-2016)
    “…Tuberculosis (TB) and HIV are among the risk factors for deep vein thrombosis (DVT). There are several challenges in the management of DVT patients with TB-HIV…”
    Get full text
    Journal Article
  10. 10

    Improvement of the patient flow in a large urban clinic with high HIV seroprevalence in Kampala, Uganda by Castelnuovo, B, Babigumira, J, Lamorde, M, Muwanga, A, Kambugu, A, Colebunders, R

    Published in International journal of STD & AIDS (01-02-2009)
    “…Antiretroviral treatment roll-out programmes in Africa often have difficulties to cope with the increasing number of clients. Based on the findings of a survey…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Cost-Utility Analysis Of Rosuvastatin Compared To Atorvastatin In Primary Prevention Of Myocardial Infarction Among HIV-Positive Patients On Haart In Uganda by Serunjogi, B, Lamorde, M

    Published in Value in health (01-10-2017)
    “…Cardiovascular disease is the leading cause of death worldwide. Three-quarters of these occur in low-middle income countries. HIV-positive patients are Jiving…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20